Haematological Products


Fulvestrant is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy. It is given by injection into a muscle.


Cytarabine, also known as cytosine arabinoside , is a chemotherapy medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and non-Hodgkin's lymphoma. It is given by injection into a vein, under the skin, or into the cerebrospinal fluid.


A cell-cycle phase nonspecific alkylating antineoplastic agent. It is a nitrogen mustard β-chloro-nitrosourea compound. It is used in the treatment of brain tumors and various other malignant neoplasms, Multiple myeloma, Hodgkin’s and Non-Hodgkin’s lymphoma.


Doxorubicin is an anthracycline type of chemotherapy that is used alone or with other chemoagents to treat several different types of cancer.


Bendamustine hydrochloride is a bifunctional chemotherapeutic agent with structurally similar to alkylating agents and purine analogues.


Lenalidomideis an immunomodulatory drug and also thalidomide analogue, It was initially intended as a treatment for multiple myeloma,


Busulfan is a bifunctional alkylating agent, having a selective immunosuppressive effect on bone marrow. It has been used in the palliative treatment of Chronic Myeloid Leukemia (CML).


Bortezomib is the first of its class to be approved for clinical use. It is a 26S proteosome inhibitor (26S proteosome is the principal regulator


Hydroxyurea has constantly evolved as a drug ever since its initial approval in CML. The drug has been extensively studied in Acute Leukemias, Sickle Cell Anaemia


Thalidomide can be compared with the Phoenix that rose from the ashes according to Greek Mythology. A drug that was banned 50 years ago after the infamous ‘thalidomide babies’ case.


Melphalan is an indispensable part of Multiple Myeloma treatment. Being available in oral dosage form, it adds to the convenience of the patient, especially in ‘all oral’ chemotherapy regimens.


Chlorambucil is a classic oral alkylating that was the standard initial treatment of Chronic Lymphocytic Leukemia (CLL) for many years.


Fludarabine is a purine analogue that has replaced traditional alkylating agent based standard initial treatment of Chronic Lymphocytic Leukemia (CLL)


The discovery of imatinib, a signal transduction inhibitor, towards the end of the last century revolutionized the treatment of Chronic Myelogenous Leukemia (CML)